The Allergic Rhinitis Market
Outlook and Analysis by Type (Seasonal
Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic
Rhinitis), Treatment (Antihistamines, Corticosteroids, Immunotherapy,
Decongestants and others), Route of Administration (Oral, Nasal and others),
Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Stores)
- Forecast till 2030
Weakening immunity has primarily
contributed to the widespread occurrence of allergy cases globally. Market
reports associated with the healthcare sector made accessible by Market
Research Future along with published reports on other sectors have been lately
put out along with a report on this industry. The market is set to expand at a
CAGR of 3.30 % while grossing revenues worth $ 15 billion in the duration of
the forecast period.
Animal dander, mold, pollen, and
dust have been identified as some of the triggering agents for allergic
rhinitis, which are increasingly found at some times of the year as compared to
the rest of the year. Since the degree of control for limiting the contraction
of allergic rhinitis is severely restricted, the measure for controls and
treatment are gaining increasing demand in the market. The treatment and
prevention methods which are handy and provide quick relief are expected to
grow favorably over the forecast period.
Segmental Analysis
The segmentation of the allergic rhinitis market
share comprises of types, treatment, and test. The
types of the allergic rhinitis segment consists of perennial, seasonal, and
non-allergic rhinitis. On the basis of the treatment, the segmentation
comprises of antihistamines, immunotherapy, eye drops, decongestants, nasal
sprays, sublingual immunotherapy (SLIT) and home remedies. The antihistamine
segment is additionally sub-segmented into drugs like Xyzal, Clarinex, Allegra,
And Zyrtec. The decongestants segment is further sub-segmented into Sudafed,
Sudafed PE, Afrin Nasal Spray, And Zyrtec-D. The test segment of the market
comprises of igE RAST test, skin tests, and complete blood count.
Detailed Regional Analysis
The regional analysis of the market
comprises of regions such as Europe, America, Asia Pacific along with the
Middle East and Africa. The North American region is controlling the allergic
rhinitis drugs market. The U.S. has the maximum cases of hay fever that
are detected annually. The next major market of allergic rhinitis market
is the European region. The allergy immunotherapy market is currently observing a high development owing to better
awareness about this disease and its treatment. The growing occurrence of
allergic rhinitis in this region is attributed to the growing population. Japan
has the next highest frequency in terms of cases detected of allergic rhinitis
after the US.
Competitive Analysis
The external factors are defining the
market’s course which is contingent on the practices and the strategic roadmaps
that are used by the market players. The revolutionary innovations in products
and services are the chief factor contributing to the market's success and
influencing the trends that have gained importance in the market. The
availability of a proficient labor force along with resources is growing the
overall market development. The market is moderately well defined in terms of
its volume and value. The foremost success factors and competitors’
inclinations are increasingly inclined to the strategies being used by market companies.
The primary companies that are
profiled in this report are GSK (UK), Sanofi (France), Chong kun Dang
Pharmaceutical Corp. (South Korea), Himalaya (India), J&J (US), Faes, Farma
(Spain), Cigna (USA), Merck (US), Hisamitsu Pharmaceutical Co.in (Japan),
Glenmark Pharmaceutical (India), Ampio pharmaceutical Inc. (US), Olain Farm
(Lavtvia) and others.
Industry Updates:
Aug 2018 Glenmark’s
New Drug Application for Ryaltris which is an investigational fixed-dose
combination nasal spray for periodic allergic rhinitis (SAR) in patients 12
years of age and older. The nasal spray of Ryaltris combines an antihistamine
and a steroid and is also considered Glenmark's foremost respiratory pipeline
runner.
About
Market Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting
Services. MRFR team have supreme objective to provide the optimum quality market
research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research
and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment